drugset / Trial / NCT01233843
Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that induction chemotherapy followed by radiation therapy plus Cetuximab will give better results than the validated treatment (chemoradiotherapy), for treatment of locoregional advanced head and neck cancers.
Timeline
- Start
- 2009-05-18
- Primary completion
- 2018-11-06
- Completion
- 2018-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 70 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 600 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 1000 mg/m2 | — |